ConjuChem Information

ConjuChem, LLC is a privately biotechnology company with a corporate office located in Los Angeles, California. ConjuChem is owned by NantWorks, LLC. ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DACâ„¢) and Preformed Conjugate-Drug Affinity Complex (PC-DACâ„¢). When applied to a given peptide, DACâ„¢ and PC- DACâ„¢ can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.

Website	http://www.conjuchem.com
Revenue	$6 million
Employees	10 (2 on RocketReach)
Founded	1997
Phone	+1 650-321-5544
Industry	Biotechnology, Pharmaceuticals, Biotechnology Research, Healthcare, Science and Engineering, Drug Manufacturing & Research
Keywords	Biotechnology, Therapeutic Peptides, Drug Development, Clinical Development, Pharmaceutical Research, Drug Discovery, Peptide Therapeutics, Preclinical Development, Biotechnology Research, Pharmaceutical Development, Novel Medicines, Peptide Drugs, Pharmaceutical, Biotech, Therapeutics, Medicine
Competitors	Novartis, Merck & Co., Inc., AstraZeneca, Genentech, Amgen, Regeneron, Biogen, Lilly India, Ablynx, PeptiDream Inc. +39 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies